This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

RUTI Vaccine

Archivel Farma S.L.

Drug Names(s): RUTI polyantigenic Vaccine

Description: RUTI is a poly-antigenic vaccine manufactured from fragments of non-replicative bacilli and enables recognition of antigens of bacilli in replication or non-replicative bacilli, thereby controlling reinfection more efficiently.

Deal Structure: The RUTI vaccine is the result of the partnership between the Badalona-based Institut dInvestigaci en Cincies de la Salut Germans Trias i Pujol Foundation and Archivel Farma.


RUTI Vaccine News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug